• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

方法至关重要:支化和葡萄糖-聚(乳酸-共-乙醇酸)聚合物的特性描述技术的发展。

Method matters: Development of characterization techniques for branched and glucose-poly(lactide-co-glycolide) polymers.

机构信息

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA.

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA; Purdue University, Biomedical Engineering and Pharmaceutics, 206 S. Martin Jischke Drive, West Lafayette, IN 47907, USA.

出版信息

J Control Release. 2020 Apr 10;320:484-494. doi: 10.1016/j.jconrel.2020.02.005. Epub 2020 Feb 3.

DOI:10.1016/j.jconrel.2020.02.005
PMID:32027937
Abstract

Defining the qualitative sameness of parenteral formulations comprised of poly(lactide-co-glycolide) (PLGA) requires assays of the relevant properties of polymer from each formulation. Gel-permeation chromatography with quaternary detection (GPC-4D) has been previously applied to other polymers, and the relevant mathematical parameters for their characterization are available; however, such parameters have not been described for branched PLGA polymers. Little information is available for the determination of glucose within glucose-PLGA (Glu-PLGA) branched polymers. This study describes the experimental methods of defining the mathematical parameters for characterization of branched PLGA polymers and the validation of these parameters using known branched-PLGA standards. The glucose, used as an initiator, was tracked through the synthesis of Glu-PLGA by both C NMR and enzymatic analysis. The analytical determination of the relevant parameters defining Glu-PLGA, such as the branching number, and the presence of glucose, requires the use of appropriate procedures experimentally validated in a systematic manner. The procedures described in this study were developed for characterization of Glu-PLGA with the lactide:glycolide (L:G) ratio of 55:45 used in Sandostatin® LAR. The procedures can also be used for characterization of Glu-PLGAs made of different L:G ratios.

摘要

定义由聚(丙交酯-乙交酯)(PLGA)组成的注射制剂的定性等同性需要对每个制剂的聚合物的相关性质进行测定。先前已经将带有四元检测的凝胶渗透色谱法(GPC-4D)应用于其他聚合物,并且可获得其特征化的相关数学参数;然而,尚未针对支化 PLGA 聚合物描述这些参数。关于葡萄糖-PLGA(Glu-PLGA)支化聚合物中葡萄糖的测定,信息很少。本研究描述了定义支化 PLGA 聚合物特征化的数学参数的实验方法,并使用已知的支化-PLGA 标准对这些参数进行了验证。葡萄糖作为引发剂,通过 C NMR 和酶分析跟踪 Glu-PLGA 的合成。通过适当的程序从实验上以系统的方式进行验证,才能对定义 Glu-PLGA 的相关参数,如支化数和葡萄糖的存在进行分析测定。本研究中描述的程序是为了表征使用在 Sandostatin® LAR 中的 55:45 丙交酯:乙交酯(L:G)比的 Glu-PLGA 而开发的。这些程序也可用于表征由不同 L:G 比制成的 Glu-PLGAs。

相似文献

1
Method matters: Development of characterization techniques for branched and glucose-poly(lactide-co-glycolide) polymers.方法至关重要:支化和葡萄糖-聚(乳酸-共-乙醇酸)聚合物的特性描述技术的发展。
J Control Release. 2020 Apr 10;320:484-494. doi: 10.1016/j.jconrel.2020.02.005. Epub 2020 Feb 3.
2
Characterization of branched poly(lactide-co-glycolide) polymers used in injectable, long-acting formulations.用于可注射长效制剂的支化聚(丙交酯-乙交酯)聚合物的特性描述。
J Control Release. 2019 Jun 28;304:75-89. doi: 10.1016/j.jconrel.2019.04.039. Epub 2019 May 2.
3
Complex sameness: Separation of mixed poly(lactide-co-glycolide)s based on the lactide:glycolide ratio.复杂的相同性:基于丙交酯:乙交酯比例分离混合聚(丙交酯-共-乙交酯)。
J Control Release. 2019 Apr 28;300:174-184. doi: 10.1016/j.jconrel.2019.03.002. Epub 2019 Mar 8.
4
Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation.可注射、长效 PLGA 制剂:分析 PLGA 和了解微球形成。
J Control Release. 2019 Jun 28;304:125-134. doi: 10.1016/j.jconrel.2019.05.003. Epub 2019 May 6.
5
Analysis of semi-solvent effects for PLGA polymers.聚乳酸-羟基乙酸共聚物(PLGA)聚合物的半溶剂效应分析。
Int J Pharm. 2021 Jun 1;602:120627. doi: 10.1016/j.ijpharm.2021.120627. Epub 2021 Apr 27.
6
Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.万古霉素从聚(D,L-丙交酯)和聚(丙交酯-共-乙交酯)圆片中的释放
J Microencapsul. 2002 Jan-Feb;19(1):83-94. doi: 10.1080/02652040110065404.
7
Printability and Critical Insight into Polymer Properties during Direct-Extrusion Based 3D Printing of Medical Grade Polylactide and Copolyesters.直接挤出式 3D 打印医用级聚乳酸及其共聚酯的可印刷性和对聚合物性能的关键洞察
Biomacromolecules. 2020 Feb 10;21(2):388-396. doi: 10.1021/acs.biomac.9b01112. Epub 2019 Oct 11.
8
Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.用于粒细胞巨噬细胞集落刺激因子控释的聚乙交酯-共-D,L-丙交酯/聚-D,L-丙交酯微球的表征
Pharm Res. 1997 Oct;14(10):1422-30. doi: 10.1023/a:1012176823155.
9
Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles.聚(丙交酯-乙交酯)微球的配方组成、制造工艺和特性描述。
J Control Release. 2021 Jan 10;329:1150-1161. doi: 10.1016/j.jconrel.2020.10.044. Epub 2020 Oct 24.
10
A protocol for assay of poly(lactide-co-glycolide) in clinical products.临床产品中聚丙交酯-乙交酯的检测方案。
Int J Pharm. 2015 Nov 10;495(1):87-92. doi: 10.1016/j.ijpharm.2015.08.063. Epub 2015 Aug 28.

引用本文的文献

1
PLGA-based long-acting injectable (LAI) formulations.基于聚乳酸-羟基乙酸共聚物的长效注射剂(LAI)制剂。
J Control Release. 2025 Jun 10;382:113758. doi: 10.1016/j.jconrel.2025.113758. Epub 2025 Apr 21.
2
In vitro-in vivo correlation (IVIVC) development for long-acting injectable drug products based on poly(lactide-co-glycolide).基于聚(丙交酯-乙交酯)的长效注射用药物产品的体外-体内相关性(IVIVC)研究
J Control Release. 2025 Jan 10;377:186-196. doi: 10.1016/j.jconrel.2024.11.021. Epub 2024 Nov 19.
3
Scanning Analysis of Sequential Semisolvent Vapor Impact To Study Naltrexone Release from Poly(lactide-co-glycolide) Microparticles.
顺序半挥发性溶剂蒸汽冲击扫描分析研究纳曲酮从聚(丙交酯-共-乙交酯)微球中的释放。
Mol Pharm. 2022 Nov 7;19(11):4286-4298. doi: 10.1021/acs.molpharmaceut.2c00595. Epub 2022 Sep 27.
4
PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery.PLGA/PLA 基长效注射储库微球的临床应用:蛋白/肽给药的生产和特性概述。
Int J Mol Sci. 2021 Aug 18;22(16):8884. doi: 10.3390/ijms22168884.
5
Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.基于质量源于设计的聚(乳酸-共-乙醇酸)微球的生产:综述。
Drug Deliv. 2021 Dec;28(1):1342-1355. doi: 10.1080/10717544.2021.1943056.
6
Key Factor Study for Generic Long-Acting PLGA Microspheres Based on a Reverse Engineering of Vivitrol.基于 Vivitrol 反向工程的通用长效 PLGA 微球的关键因素研究。
Molecules. 2021 Feb 25;26(5):1247. doi: 10.3390/molecules26051247.